Acotec Scientific Wins PRC Approval for Coronary Over-the-Wire Balloon Catheter

Reuters
11/18
Acotec Scientific Wins PRC Approval for Coronary Over-the-Wire Balloon Catheter

Acotec Scientific Holdings Limited has announced that it has received registration approval from the PRC National Medical Products Administration for its Coronary Over-the-Wire Balloon Dilatation Catheter, Jingyi. The device is indicated for dilating coronary artery or coronary artery bypass vessel stenosis to improve myocardial perfusion, with certain configurations also approved for post-stent dilation. The company highlighted that Jingyi features a semi-compliant balloon and an optimized delivery system designed for improved crossability and pushability, making it suitable for complex lesions. Acotec plans to commence marketing activities for the product in the Chinese market at an appropriate time. The company cautioned that successful commercialization is not guaranteed. No other organizations were mentioned as recipients of this regulatory approval.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acotec Scientific Holdings Ltd. published the original content used to generate this news brief on November 18, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10